The Enterprise Value as of September 2024 (TTM) for RVL Pharmaceuticals plc (RVLP) is 42.13M

According to RVL Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Enterprise Value is 42.13M. This represents a change of -69.29% compared to the average of 137.17M of the last 4 quarters.

RVL Pharmaceuticals plc (RVLP) Historical Enterprise Value (quarterly & annually)

How has RVLP Enterprise Value performed in the past?

The mean historical Enterprise Value of RVL Pharmaceuticals plc over the last ten years is 419.60M. The current 42.13M Enterprise Value has changed 904.04% with respect to the historical average. Over the past ten years (40 quarters), RVLP's Enterprise Value was at its highest in in the June 2018 quarter at 706.85M. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.

RVL Pharmaceuticals plc (RVLP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RVL Pharmaceuticals plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RVL Pharmaceuticals plc (RVLP) Average Enterprise Value

How has RVLP Enterprise Value performed in the past?

The current Enterprise Value of RVL Pharmaceuticals plc (RVLP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RVL Pharmaceuticals plc (RVLP) Enterprise Value vs. Peers

How is RVLP’s Enterprise Value compared to its peers?

RVL Pharmaceuticals plc’s Enterprise Value is less than Molecular Partners AG (0), greater than MediciNova, Inc. (-1929773.37), less than Anebulo Pharmaceuticals, Inc. (59.15M), greater than Champions Oncology, Inc. (41.53M), less than Cyteir Therapeutics, Inc. (62.59M), greater than Aerovate Therapeutics, Inc. (-20511738.00), greater than Adagene Inc. (24.46M), greater than Acrivon Therapeutics, Inc. Common Stock (40.66M), less than Rezolute, Inc. (208.47M), less than AN2 Therapeutics, Inc. (237.24M), greater than PMV Pharmaceuticals, Inc. (3.67M), greater than Eliem Therapeutics, Inc. (40.92M), less than HCW Biologics Inc. (272.53M), greater than Sensei Biotherapeutics, Inc. (35.48M), greater than NextCure, Inc. (8.47M), greater than Nuvation Bio Inc. (25.04M), less than Graphite Bio, Inc. (947.94M), greater than Merrimack Pharmaceuticals, Inc. (-15007658.00), greater than null (-10189682.00),

Build a custom stock screener for RVL Pharmaceuticals plc (RVLP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RVL Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RVL Pharmaceuticals plc (RVLP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RVL Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.